We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$36.9B
AUM Growth
+$1.94B
Cap. Flow
+$154M
Cap. Flow %
0.42%
Top 10 Hldgs %
4.62%
Holding
3,025
New
132
Increased
1,201
Reduced
1,478
Closed
188

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$57.1M
2
INCY icon
Incyte
INCY
+$53M
3
SD icon
SandRidge Energy
SD
+$46.7M
4
SNPS icon
Synopsys
SNPS
+$46.3M
5
AMD icon
Advanced Micro Devices
AMD
+$41.3M

Sector Composition

Rank Sector Weight
1 Technology 13.19%
2 Financials 13.13%
3 Healthcare 11.29%
4 Industrials 11.08%
5 Consumer Discretionary 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVIA
2776
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$21K ﹤0.01%
+29,576
New +$27.5K
IPAS
2777
DELISTED
Ipass Inc Common Stock
IPAS
$21K ﹤0.01%
1,767
+10
+0.6% +$137
CWEN.A
2778
DELISTED
Clearway Energy Class A
CWEN.A
$20K ﹤0.01%
1,163
-2,079
-64% -$34.1K
WYY icon
2779
WidePoint Corp
WYY
$101M
$20K ﹤0.01%
4,533
+27
+0.6% +$194
STCN
2780
DELISTED
Steel Connect, Inc. Common Stock
STCN
$20K ﹤0.01%
+1,207
New +$19.6K
CASM
2781
DELISTED
CAS Medical Systems, Inc.
CASM
$20K ﹤0.01%
13,699
+1,182
+9% +$1.8K
AMPE
2782
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$19K ﹤0.01%
82
HGT
2783
DELISTED
Hugoton Royalty Trust
HGT
$19K ﹤0.01%
10,185
+61
+0.6% +$118
VNCE icon
2784
Vince Holding Corp
VNCE
$81.3M
$18K ﹤0.01%
+1,168
New +$28K
NLST
2785
DELISTED
Netlist, Inc.
NLST
$18K ﹤0.01%
18,103
+4,008
+28% +$4K
CYTR
2786
DELISTED
CytRx Corp
CYTR
$18K ﹤0.01%
6,761
+4,129
+157% +$10.5K
GROW icon
2787
US Global Investors
GROW
$35.5M
$17K ﹤0.01%
10,795
+64
+0.6% +$107
BIOL
2788
DELISTED
Biolase, Inc.
BIOL
$17K ﹤0.01%
1
EVEP
2789
DELISTED
EV Energy Partners, L.P.
EVEP
$17K ﹤0.01%
11,606
-869
-7% -$1.56K
WSTL
2790
DELISTED
Westell Technologies Inc
WSTL
$17K ﹤0.01%
5,941
+35
+0.6% +$96
EGY icon
2791
Vaalco Energy
EGY
$570M
$16K ﹤0.01%
17,237
+3,603
+26% +$3.88K
ARQL
2792
DELISTED
Arqule Inc
ARQL
$16K ﹤0.01%
14,749
+88
+0.6% +$117
SNMX
2793
DELISTED
Senomyx, Inc.
SNMX
$15K ﹤0.01%
+15,099
New +$16.7K
REXX
2794
DELISTED
Rex Energy Corporation
REXX
$15K ﹤0.01%
+3,290
New +$19.8K
UAMY icon
2795
United States Antimony
UAMY
$751M
$13K ﹤0.01%
25,577
+2,152
+9% +$867
VGZ icon
2796
Vista Gold
VGZ
$251M
$13K ﹤0.01%
12,917
+77
+0.6% +$80
VXRT
2797
DELISTED
Vaxart
VXRT
$13K ﹤0.01%
1,834
+74
+4% +$757
MTEM
2798
DELISTED
Molecular Templates, Inc.
MTEM
$13K ﹤0.01%
138
+1
+0.7% +$94
ALT icon
2799
Altimmune
ALT
$552M
$12K ﹤0.01%
52
DSS icon
2800
DSS Inc
DSS
$5.39M
$12K ﹤0.01%
18

Similar funds

Guggenheim Capital's Q1 2017 Portfolio in Review

As of Q1 2017, Guggenheim Capital held 3,025 positions worth $36.9B, up 5.5% from $35B the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.

Guggenheim Capital's Q1 2017 filing shows 132 new, 1,201 increased, 1,478 reduced and 188 closed positions. Its largest new stake was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 1,177,888 shares worth $26.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $92.1M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q1 2017 buy was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 1,177,888 shares worth $26.2M.
  • Guggenheim Capital added most to Idexx Laboratories in Q1 2017, an estimated $57.1M increase.
  • Guggenheim Capital's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92.1M.
  • Guggenheim Capital fully exited Linear Technology Corp in Q1 2017, selling an estimated $72.6M.
  • Guggenheim Capital's ten largest holdings make up 4.6% of its $36.9B portfolio in Q1 2017.
  • Guggenheim Capital opened 132 new positions and closed 188 in Q1 2017.
  • Guggenheim Capital's portfolio value rose 5.5% quarter-over-quarter to $36.9B.

Based on Guggenheim Capital's 13F filing for Q1 2017, filed 15 May 2017.